The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives.

The rapidly expanding scenario of treatment options for patients affected by prostate cancer (PC) is leading to improved outcomes; however, PC still represents one of the most frequent causes of male mortality.